Search alternatives:
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
b decrease » a decrease (Expand Search), b1 decreased (Expand Search), ob decreased (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
16 b » 16 _ (Expand Search), 1 b (Expand Search), 6 b (Expand Search)
_ we » _ web (Expand Search), _ wet (Expand Search), _ e (Expand Search)
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
b decrease » a decrease (Expand Search), b1 decreased (Expand Search), ob decreased (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
16 b » 16 _ (Expand Search), 1 b (Expand Search), 6 b (Expand Search)
_ we » _ web (Expand Search), _ wet (Expand Search), _ e (Expand Search)
-
1
-
2
GSK343 decreased tumor stemness.
Published 2021“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”
-
3
-
4
-
5
-
6
Downregulation of DOM decreases the abundance of PER and TIM.
Published 2019“…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
-
7
-
8
-
9
-
10
-
11
-
12
mGluR5 receptor decreased glycinergic currents.
Published 2019“…(<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”
-
13
Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.
Published 2023“…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…”
-
14
-
15
-
16
-
17
FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma.
Published 2019“…When tumors reached an average of 150 mm<sup>3</sup>, mice were randomized to receive vehicle (ORA-Plus, 50 μL, n = 7) or FTY720 (10 mg/kg body weight/day in ORA-Plus, 50 μL, n = 7) by oral gavage for 16 days. …”
-
18
-
19
DataSheet_1_IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibod...
Published 2021“…We assessed the changes of IL-40 levels in RA patients following the B cell depletion by rituximab (n=29) or after the TNF inhibition by adalimumab (n=25). …”
-
20